Previous close | 3.3500 |
Open | 3.3400 |
Bid | 3.5000 x 400 |
Ask | 3.5600 x 100 |
Day's range | 3.3400 - 3.6900 |
52-week range | 2.2600 - 13.4900 |
Volume | |
Avg. volume | 33,446 |
Market cap | 24.897M |
Beta (5Y monthly) | 0.12 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Minerva Neurosciences (NERV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
In this piece, we will take a look at the 12 best performing biotechnology stocks in 2023. If you want to skip our introduction to the biotechnology industry and some top players, then check out 5 Best Performing Biotech Stocks in 2023. Biotechnology is one of the hottest industries these days and one that has […]